Viewing Study NCT06649006


Ignite Creation Date: 2025-12-26 @ 5:17 PM
Ignite Modification Date: 2026-01-01 @ 4:29 AM
Study NCT ID: NCT06649006
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-20
First Post: 2024-10-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL)
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module